ArticleCancers2024
Clinical-Demographic Profile, Prognostic Factors and Outcomes in Classic Follicular Lymphoma Stratified by Staging and Tumor Burden: Real-World Evidence from a Large Latin American Cohort.
Daniel Silva Nogueira, Luís Alberto de Pádua Covas Lage, Cadiele Oliana Reichert, Hebert Fabrício Culler, Fábio Alessandro de Freitas, João Antônio Tavares Mendes, Ana Carolina Maia Gouveia, Renata de Oliveira Costa, Cristiane Rúbia Ferreira, Jéssica Ruivo Maximino and 5 more
Abstract read
In one paragraphArticle in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Daniel Silva NogueiraDepartment of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.ORCID 0000-0002-4741-8901 Luís Alberto de Pádua Covas LageDepartment of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.ORCID 0000-0002-9228-3276 Cadiele Oliana ReichertDepartment of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.
Hebert Fabrício CullerDepartment of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.
Fábio Alessandro de FreitasDepartment of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.ORCID 0000-0001-5745-7843 João Antônio Tavares MendesLaboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.
Ana Carolina Maia GouveiaLaboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.ORCID 0009-0004-0221-873X Renata de Oliveira CostaDepartment of Hematology, Faculty of Medicine, Centro Universitário Lusíada (Unilus), Santos 11050-071, Brazil.
Cristiane Rúbia FerreiraDepartment of Pathology, University Hospital (HU), University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.ORCID 0000-0003-1774-4316 Jéssica Ruivo MaximinoLaboratory of Translational Neurology (LIM-45), University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.
Sérgio Paulo BydlowskiDepartment of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.ORCID 0000-0002-7582-5942 Carlos Alejandro Murga ZamalloaDepartment of Pathology, University of Illinois at Chicago (UIC), Chicago, IL 60607, USA.ORCID 0000-0002-2238-5066 Vanderson RochaDepartment of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.
Débora LevyLaboratory of Immunology and Histocompatibility (LIM-19), University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.ORCID 0000-0001-7492-997X Juliana PereiraDepartment of Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of Sao Paulo (FM-USP), Sao Paulo 05508-090, Brazil.ORCID 0000-0002-0655-2821 Funding
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) 2020/13246-1
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
clinical outcomesfollicular lymphoma (FL)histological transformation (HT) to high-grade B-cell lymphoma (HGBCL)prognostic factorsprogression of disease within 24 months from initial therapy (POD-24)stagingtreatment modalitiestumor burden
Identifiers
PMID39682103
PMCPMC11640734
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390